Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck | MicrobiomeTrials← Back to trialsNCT03139058
Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck
TERMINATEDNAINTERVENTIONAL
Trial Details
Start: 2018-12-13Est. Completion: 2020-09-09
Enrollment target: 2 participants Locations- CHU Amiens Picardie, Amiens, Picardie, France
Other microbiome trials you might be interested in
Non-alcoholic Fatty Liver Disease
The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis…
Chandler, United StatesEst. completion Mar 29, 2028
Chronic Hepatitis B Infection
France is a low-endemicity country for hepatitis B virus (HBV) infection. In 2016, the prevalence of chronic HBV infecti…
Créteil, FranceEst. completion Sep 1, 2029
Recruiting
Non-alcoholic Fatty Liver Disease
This study will evaluate the safety and tolerability of Efimosfermin Alfa for participants with known or suspected MASH …
Arcadia, United StatesEst. completion Mar 24, 2028